See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.78▲ 1.32%
← MSCI page
XStocksXray
Research report · 22 October 2026

MSCI Inc. (MSCI)

Financials · Financial Exchanges & Data · US stock · price as of 22 Oct 2026

Key indicators

Price$620.24
52-week range$501.08 – $644.77
Market cap$45.2B
P/E (trailing)34.2×
EV / EBITDA27.2×
Free-cash-flow yield3.5%
Dividend yield1.3%
Revenue (last 12 months)$3.3B
Revenue growth (3y a year)11.7%
Operating margin55.7%
Return on invested capital45.3%
Net debt / EBITDA3.3×

Fair value

Fair value (average of valid models)$645.01 middle half of models $601 – $741
Versus priceFair+4% to fair value
P/E multiple$638.25
P/S multiple$606.96
EV/EBITDA multiple$619.72
EV/EBIT multiple$670.81
EV/revenue multiple$599.19
10-year DCF, EBITDA exit$746.09
5-year DCF, EBITDA exit$750.22
10-year DCF, revenue exit$739.57
5-year DCF, revenue exit$741.45
10-year DCF, growth exit$429.16
5-year DCF, growth exit$391.93
Dividend discount, stable$700.98
Dividend discount, multi-stage$989.61
Earnings power value$406.21
Model uncertaintyHigh

X-Ray Score

58/ 100 · High confidence · ahead of 76% of sector peers
Valuation28
Growth65
Profitability92
Financial health49
Dividends54

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

336443550657764Fair value $6452021-102023-012024-042025-072026-10

Executive summary

MSCI provides investment decision support tools, including stock market indexes, portfolio and risk analytics, and environmental, social and governance research. Asset managers, banks and institutional investors use its products to build portfolios, benchmark performance and measure risk. A large share of revenue comes from subscriptions and licence fees, including fees based on assets in investment products that track its indexes, which creates a recurring revenue stream.

MSCI Inc. generated $3.3 billion of revenue in the last twelve months, with sales that expanded at 11.7% a year across three years. Leverage, measured as net debt to EBITDA, is 3.3 times. The operating margin is 55.7% and the return on invested capital is 45%. Shareholders receive a dividend, yielding 1.3%.

StocksXray gives MSCI Inc. an X-Ray Score of 58 out of 100 (high confidence), ahead of 76% of the S&P 500 stocks in its sector. Its strongest lens is profitability (92) and its weakest is valuation (28).

Our fair value (the average of the valid models) is $645.01 (range $601.13 to $740.98). At $620.24 the stock trades 4% below that value, so the label is "Fair" with high model uncertainty. Fair value is a range, not a price target.

stocksxray.com · page 1
XStocksXray
MSCI Inc. (MSCI)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

FY2021FY2022FY2023FY2024FY2025Now
Price$579.53$444.29$546.04$585.94$567.39$620.24
Market cap$48.4B$36.1B$43.6B$46.3B$43.5B$45.2B
P/E66.6×41.4×37.9×41.7×36.2×34.2×
EV / revenue25.0×17.6×18.8×17.6×15.7×15.4×
EV / EBITDA46.4×32.1×33.9×32.6×28.3×27.2×
Price / free cash flow52.4×33.4×35.9×31.5×28.1×28.3×
Free-cash-flow yield1.9%3.0%2.8%3.2%3.6%3.5%
Price / book––––––
Dividend yield0.63%1.03%1.01%1.09%1.27%1.28%

Fundamentals checklist ● 7 Good · ● 3 Average · ● 5 Bad · each check graded against the sector

Cash quality

Earnings backed by cash−4.8%Good
Free-cash-flow yield3.5%Bad

Risk models

Altman Z score5.1×Good
Piotroski F-Score8 of 9Good

Growth

EPS growth (3y)13.5%Average
Free-cash-flow growth (3y)12.7%Average
Revenue growth (3y)11.7%Good
Growth consistency100%Good

Balance sheet

Current ratio0.9×Bad
Net debt / EBITDA3.3×Bad
Interest cover7.2×Bad

Valuation

Fair value vs price1.0×Average
EBIT / EV yield3.6%Bad

Profitability

Return on invested capital45.3%Good
Operating margin55.7%Good

Red flags

  • Negative equity — Book equity is negative
  • Negative equity — Book equity is negative
  • Negative equity — Book equity is negative
  • Negative equity — Book equity is negative
  • Negative equity — Book equity is negative
stocksxray.com · page 2
XStocksXray
MSCI Inc. (MSCI)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statementFY21FY22FY23FY24FY25LTM
Revenue2,0442,2492,5292,8563,1343,334
Gross profit––––––
Operating income1,0731,2081,3851,5291,7141,856
Net income7268711,1491,1091,2021,358
Diluted EPS ($)8.7010.7214.3914.0515.6918.14
Free cash flow9231,0821,2131,4681,5491,598
Gross margin––––––
Operating margin52.5%53.7%54.8%53.5%54.7%55.7%
Net margin35.5%38.7%45.4%38.8%38.4%40.7%
Balance sheetFY21FY22FY23FY24FY25LTM
Total assets5,5074,9985,5185,4455,7035,603
Cash1,421994462409515356
Total debt4,1614,5124,5084,5116,2026,380
Equity-163-1,008-740-940-2,655-2,690
Dividend per share ($)3.644.585.526.407.207.70

Revenue and net income US$ billions: navy revenue, teal net income

FY21FY22FY23FY24FY25

Margins blue gross, teal operating, brown net

0%18%37%55%FY21FY22FY23FY24FY25

Latest quarters

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue ($M)746773793823851867
Growth vs a year earlier+9.7%+9.1%+9.5%+10.6%+14.1%+12.2%
Net income ($M)289304325285406342
Diluted EPS ($)3.713.924.25–5.534.69
stocksxray.com · page 3
XStocksXray
MSCI Inc. (MSCI)

Peers in Financial Exchanges & Data

CompanyX-Ray
MSCI · MSCI Inc.58
MCO · Moodys Corp61
CBOE · Cboe Global Markets, Inc.58
FDS · Factset Research Systems I...58
ICE · Intercontinental Exchange,...52

Market Compass outlook for Financials: Favourable (71/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week+7.9%
1 month+13.0%
3 months+9.0%
6 months+2.7%
1 year+17.0%
3 years+31.6%
5 years+1.2%

Technical summary

DailyBullish12 bullish · 0 neutral · 4 bearish
WeeklyStrongly bullish11 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish
50-day / 200-day average$561.21 / $569.86
52-week low / high$501.08 / $644.77
Classic pivot, support and resistanceS2 591.79 · S1 606.01 · P – · R1 629.32 · R2 638.41

Recent dividends

Ex-dividend dateAmount per share
14 Aug 2026$2.0500
15 May 2026$2.0500
13 Feb 2026$2.0500
14 Nov 2025$1.8000
15 Aug 2025$1.8000
16 May 2025$1.8000
stocksxray.com · page 4
XStocksXray
MSCI Inc. (MSCI)

Strengths

  • Return on invested capital of 45.3% is ahead of 93% of its sector peers.
  • Operating margin of 55.7% is ahead of 88% of its sector peers.
  • Revenue growth of 11.7% a year over three years is ahead of 75% of its sector peers.
  • Piotroski F-Score of 8 out of 9: most of the nine accounting health tests pass.
  • Has raised its dividend for 7 years in a row.

Risks and weak spots

  • Free-cash-flow yield is weak against Financials peers (3.5%).
  • Current ratio is weak against Financials peers (0.9×).
  • Net debt / EBITDA is weak against Financials peers (3.3×).
  • Interest cover is weak against Financials peers (7.2×).
  • EBIT / EV yield is weak against Financials peers (3.6%).
  • Red flag: Negative equity (Book equity is negative).
  • Red flag: Negative equity (Book equity is negative).
  • Red flag: Negative equity (Book equity is negative).

Latest SEC filings

DateFormItems
20 Oct 202610-Q
20 Oct 20268-K2.02,9.01
7 Aug 20268-K5.02
21 Jul 202610-Q
21 Jul 20268-K2.02,9.01
23 Apr 20268-K5.07
21 Apr 202610-Q
21 Apr 20268-K2.02,9.01

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value is the average of up to 15 valuation models, most of them anchored to the company's own multiples, so it stays near the price and should be read as a range, not a point. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.

stocksxray.com · page 5 · generated 23 Oct 2026